| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/26/2008 | EP1901734A2 Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol |
| 03/26/2008 | EP1901733A1 Use of huperzine for disorders |
| 03/26/2008 | EP1901732A2 Use of activators of the soluble guanylate cyclase for promoting the healing of wounds |
| 03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/26/2008 | EP1901730A1 Use of soluble guanylate cyclase activators for treating reperfusion damage |
| 03/26/2008 | EP1901729A1 Pharmaceutical formulations of hdac inhibitors |
| 03/26/2008 | EP1901728A2 Nanoparticulate acetaminophen formulations |
| 03/26/2008 | EP1901727A2 Methods for the treatment of substance abuse and dependence |
| 03/26/2008 | EP1901726A2 Composition for treatment of psychosis |
| 03/26/2008 | EP1901725A2 Use of pde1c and inhibitors thereof |
| 03/26/2008 | EP1901719A2 Benzimidazole formulation |
| 03/26/2008 | EP1901717A1 Orally disintegrating powder comprising cilostazol and mannitol |
| 03/26/2008 | EP1901715A2 Spray-drying process for producing a dry carnitine powder or granulate |
| 03/26/2008 | EP1901714A2 Pharmaceutical dosage forms comprising escitalopram in form of granules |
| 03/26/2008 | EP1901712A2 Therapeutic sclerosing foam made preferably xenon |
| 03/26/2008 | EP1901709A2 Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent |
| 03/26/2008 | EP1901704A1 Breath freshening and oral cleansing product comprising a magnolia bark extract and surfactant |
| 03/26/2008 | EP1901608A1 Substituted arylpyrazoles as parasiticidal agents |
| 03/26/2008 | EP1817039A4 Treatment and prevention of epilepsy |
| 03/26/2008 | EP1778685B1 Indolizine carboxamides and the aza and diaza derivatives thereof |
| 03/26/2008 | EP1747017B1 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 03/26/2008 | EP1729786A4 Administration of cisplatin by inhalation |
| 03/26/2008 | EP1727421A4 Animal cover having a temperature altering device |
| 03/26/2008 | EP1725567B1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor |
| 03/26/2008 | EP1716133B1 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
| 03/26/2008 | EP1696924B1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/26/2008 | EP1673107B1 Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker |
| 03/26/2008 | EP1660460B1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 03/26/2008 | EP1638586B1 A synergistic composition for the treatment of diabetes mellitus |
| 03/26/2008 | EP1633716A4 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors |
| 03/26/2008 | EP1613619B1 Quinazoline derivatives for treatment of cancer |
| 03/26/2008 | EP1613594B1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 03/26/2008 | EP1585497B1 Mastitis treatment with a combination of prednisolon and cephalosporin |
| 03/26/2008 | EP1583763B1 Benzoazolylpiperazine derivatives having vr1-antagonist activity |
| 03/26/2008 | EP1573450A4 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 03/26/2008 | EP1562934B1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 03/26/2008 | EP1536836B1 Topical emulsion- gel composition comprising diclofenac sodium |
| 03/26/2008 | EP1534072B1 Anthelmintic oral homogeneous veterinary pastes |
| 03/26/2008 | EP1527075B1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP1490037B1 Taste masked veterinary solid compositions |
| 03/26/2008 | EP1487461B1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 03/26/2008 | EP1476170B1 Method for curing cyanoacrylate adhesives |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | EP1465590B1 Micelle compositions containing pegylated phospholipids and a photosensitizer |
| 03/26/2008 | EP1462439B1 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | EP1439179B1 New oripavine derivatives and their uses as medicines |
| 03/26/2008 | EP1409498B1 Inositol phosphoglycan derivatives and their medical uses |
| 03/26/2008 | EP1309330B1 Photosensitizers with ligand targeting properties for tumor therapy |
| 03/26/2008 | EP1296671B1 Gabapentin analogues for sleep disorders |
| 03/26/2008 | EP1289527B1 (+)-alpha-(2,3-dimethoxyphenyl)-1(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol or its prodrug to treat dementia or cognitive impairment |
| 03/26/2008 | EP1229918B1 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 03/26/2008 | EP1196396B1 Pharmacologically active compounds with two covalently linked active principles (sodium channnel blocker/p2y2 receptor agonist) for the treatment of mucosal surfaces |
| 03/26/2008 | EP1187599B1 Stable benzimidazole formulation |
| 03/26/2008 | EP1140042B1 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites |
| 03/26/2008 | EP1003750B1 Methods of preparing and purifying 9-nitro-20-camptothecin |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | EP0781553B1 Patch for external use |
| 03/26/2008 | CN101151274A ROR alpha for promoting the induction of Bmal1 expression |
| 03/26/2008 | CN101151268A Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use |
| 03/26/2008 | CN101151267A Chemical compounds |
| 03/26/2008 | CN101151264A Crystalline form of a quinolinone-carboxamide compound |
| 03/26/2008 | CN101151263A Substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151262A Substituted piperidines |
| 03/26/2008 | CN101151261A Pyrimidine compounds having tie2 (TEK) inhibitory activity |
| 03/26/2008 | CN101151260A Benzimidazole derivative and use as angiotensin ii antagonist |
| 03/26/2008 | CN101151259A Heteroaryl urea derivatives useful for inhibiting CHKI |
| 03/26/2008 | CN101151258A Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 03/26/2008 | CN101151254A Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase |
| 03/26/2008 | CN101151252A Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 03/26/2008 | CN101151248A 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/26/2008 | CN101151247A 3,4,5-substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151246A 1-benzylindole-2-carboxamide derivatives |
| 03/26/2008 | CN101151245A Indan-amide derivatives with glycogen phosphorylase inhibitory activity |
| 03/26/2008 | CN101151244A Histamine H3 receptor agents, preparation and therapeutic uses |
| 03/26/2008 | CN101151239A Novel biaromatic compounds, inhibitors of the P2X7-receptor |
| 03/26/2008 | CN101151055A Intravascular, interstitial or intraorgan medical device comprising a nitric oxide eluting polymer and its manufacturing method |
| 03/26/2008 | CN101151051A Analgesic combination of sodium channel blockers with opioid antagonists |
| 03/26/2008 | CN101151050A Agent for control of degranulation reaction and cytokine production |
| 03/26/2008 | CN101151049A Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 03/26/2008 | CN101151048A Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 03/26/2008 | CN101151046A Anti-viral agent |
| 03/26/2008 | CN101151038A Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
| 03/26/2008 | CN101151037A Beta-cyclodextrin derivatives as antibacterial agents |
| 03/26/2008 | CN101151036A Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| 03/26/2008 | CN101151035A Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease |
| 03/26/2008 | CN101151034A Meninges nerve cell protector containing prostaglandin F2alpha derivative as effective component |
| 03/26/2008 | CN101151033A Preventive and/or therapeutic agent for rheumatoid arthritis |
| 03/26/2008 | CN101151032A Pharmaceutical composition and method using antifungal agent in combination |
| 03/26/2008 | CN101151031A Tricyclic cytoprotective compounds |
| 03/26/2008 | CN101151030A Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis |
| 03/26/2008 | CN101151029A Novel use of lignan compounds |
| 03/26/2008 | CN101151028A Topical gels compositions |
| 03/26/2008 | CN101151027A Combination of organic compounds |
| 03/26/2008 | CN101151026A O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 03/26/2008 | CN101151020A Adjuvanting material |